Forbes: Gilead-Kite: A Breakthrough. A $12 Billion Deal.

International Celebrity Challenge Arnold Schwarzenegger
November 14, 2017
Show all

Forbes: Gilead-Kite: A Breakthrough. A $12 Billion Deal.

Gilead Sciences, the leading maker of drugs for HIV and hepatitis C, made an expensive and gutsy move into the cutting edge of cancer treatment this morning, spending $11.9 billion in cash to buy Kite Pharma, the developer of a treatment that attacks tumors by genetically modifying patients’ own white blood cells.

Read more

 

Leave a Reply

Your email address will not be published. Required fields are marked *